Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy

Cancer Cell(2023)10.1016/j.ccell.2023.04.019Source: DataRank Database

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy is a research paper published in Cancer Cell (2023). On theSindex it has a DataRank of 0. It has been cited 245 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access245 citations

Download PDF

Cite:

Linked data & code

geo gen nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 23.38)OA: bronzeTopics (25)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Xiaoyang Dou ORCID,Shijie Chen ORCID,Xianbin Yu ORCID,Xiaona Huang ORCID,Linda Zhang ORCID

Live enrichment

PubMed:37236197 PMC:PMC10524856 OpenAlex:https://openalex.org/W4378213792

NCI NIH HHS

Grant: U54 CA274291

NCI NIH HHS

Grant: K12 CA139160

NIGMS NIH HHS

Grant: T32 GM007019

NCI NIH HHS

Grant: R01 CA262508

NHGRI NIH HHS

Grant: RM1 HG008935

Howard Hughes Medical Institute

FWCI

23.38

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: cc-by

journalhttp://www.cell.com/article/S1535610823001630/pdf

publisherhttp://www.cell.com/article/S1535610823001630/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610823001630?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610823001630?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2023.04.019

Fields of Study

RNA modifications and cancerCancer-related molecular mechanisms researchLung Cancer Research Studies

MeSH Terms

AnimalsGene Expression RegulationHumansNeoplasmsSignal TransductionNF-kappa BRNA-Binding ProteinsRNA HelicasesMyeloid CellsMice

Keywords

Cancer researchRadiation therapyPharmacologyChemistryBiologyMedicineInternal medicineRadiationNF-KBMdscsM6aYthdf2

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 4 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743793.v1figshare

Additional file 4 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743793figshare

Additional file 6 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743808.v1figshare

Additional file 6 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743808figshare

Additional file 7 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743817.v1figshare

Additional file 7 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743817figshare

Additional file 10 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743835.v1figshare

Additional file 10 of NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

10.6084/m9.figshare.26743835figshare

Additional file 6 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748011.v1figshare

Additional file 7 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748014figshare

Additional file 8 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748017.v1figshare

Additional file 3 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748002figshare

Additional file 5 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748008.v1figshare

Additional file 2 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26747999.v1figshare

Additional file 4 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748005figshare

Additional file 5 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748008figshare

Additional file 3 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748002.v1figshare

Additional file 4 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748005.v1figshare

Additional file 1 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26747996figshare

Additional file 6 of Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications

10.6084/m9.figshare.26748011figshare

YTHDF2 inhibition potentiates radiotherapy antitumor efficacy

FAIR Checklist

Authors (22)

Funding (6 grants)

Impact

Open Access

Topics

Linked Datasets (25)

Annotations (Europe PMC)